SMBT
CPRX

Southern Michigan Bank & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

Southern Michigan Bank & Trust’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Hold
6,000
– – 0.07% 95
2026
Q1 		$149K Buy
+6,000
New +$143K 0.06% 107

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CNAM
Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $112M AUM 76.54% 1-Year Est. Return

Southern Michigan Bank & Trust's CPRX Position: Q2 2026 in Review

Southern Michigan Bank & Trust held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 6,000 shares worth $189K. The position accounts for 0.07% of the portfolio, ranked #95.

Southern Michigan Bank & Trust first reported a position in CPRX in Q1 2026 and has held it in 2 quarters since. 88 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Southern Michigan Bank & Trust held 6,000 shares of Catalyst Pharmaceutical worth $189K as of Q2 2026.
  • Southern Michigan Bank & Trust left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up 0.07% of Southern Michigan Bank & Trust's portfolio in Q2 2026, its #95 holding.
  • Southern Michigan Bank & Trust first reported a position in Catalyst Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 88 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Southern Michigan Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.